A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants
Status:
COMPLETED
Trial end date:
2024-05-27
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the pharmacokinetics of rocatinlimab after single subcutaneous (SC) administration in healthy Chinese participants.